【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 17
2 Introduction 18
2.1 Acquired Gene or Chromosome Alterations Overview 18
3 Products under Development 19
3.1 Acquired Gene or Chromosome Alterations – Pipeline Products by Stage of Development 19
3.2 Acquired Gene or Chromosome Alterations – Pipeline Products by Territory 20
3.3 Acquired Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 21
3.4 Acquired Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 22
4 Acquired Gene or Chromosome Alterations – Pipeline Products under Development by Companies 23
4.1 Acquired Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 23
4.2 Acquired Gene or Chromosome Alterations – Pipeline Products by Stage of Development 26
5 Acquired Gene or Chromosome Alterations Companies and Product Overview 36
5.1 Abbott Diagnostics Company Overview 36
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 36
5.2 Agendia NV Company Overview 177
5.2.1 Agendia NV Pipeline Products & Ongoing Clinical Trials Overview 177
5.3 AltheaDx, Inc. Company Overview 178
5.3.1 AltheaDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 178
5.4 Amarantus Bioscience Holdings, Inc. Company Overview 181
5.4.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 181
5.5 AstraZeneca Plc Company Overview 183
5.5.1 AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview 183
5.6 AutoGenomics, Inc. Company Overview 185
5.6.1 AutoGenomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 185
5.7 Biocept, Inc. Company Overview 186
5.7.1 Biocept, Inc. Pipeline Products & Ongoing Clinical Trials Overview 186
5.8 Cepheid Company Overview 189
5.8.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 189
5.9 Chinese University of Hong Kong Company Overview 192
5.9.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 192
5.10 Columbia University Company Overview 194
5.10.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 194
5.11 Dana-Farber Cancer Institute, Inc. Company Overview 195
5.11.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 195
5.12 DiaCarta Company Overview 196
5.12.1 DiaCarta Pipeline Products & Ongoing Clinical Trials Overview 196
5.13 Exosome Diagnostics, Inc. Company Overview 197
5.13.1 Exosome Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 197
5.14 Gencurix Co., Ltd. Company Overview 198
5.14.1 Gencurix Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 198
5.15 GeneFirst Ltd Company Overview 199
5.15.1 GeneFirst Ltd Pipeline Products & Ongoing Clinical Trials Overview 199
5.16 GenMark Diagnostics, Inc. Company Overview 203
5.16.1 GenMark Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.17 Genomic Health, Inc. Company Overview 205
5.17.1 Genomic Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.18 Genomic Vision Company Overview 207
5.18.1 Genomic Vision Pipeline Products & Ongoing Clinical Trials Overview 207
5.19 GenomicTree, Inc. Company Overview 210
5.19.1 GenomicTree, Inc. Pipeline Products & Ongoing Clinical Trials Overview 210
5.20 German Cancer Research Center Company Overview 212
5.20.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 212
5.21 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 214
5.21.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 214
5.22 Harvard University Company Overview 216
5.22.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 216
5.23 Helmholtz Centre for Infection Research Company Overview 217
5.23.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 217
5.24 HistoRx, Inc. (Inactive) Company Overview 218
5.24.1 HistoRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 218
5.25 Illumina, Inc. Company Overview 220
5.25.1 Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 220
5.26 Insight Genetics, Inc. Company Overview 223
5.26.1 Insight Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 223
5.27 InVivoScribe Technologies, Inc. Company Overview 225
5.27.1 InVivoScribe Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 225
5.28 Med BioGene Inc. Company Overview 226
5.28.1 Med BioGene Inc. Pipeline Products & Ongoing Clinical Trials Overview 226
5.29 Merrimack Pharmaceuticals, Inc. Company Overview 227
5.29.1 Merrimack Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 227
5.30 MolecularMD, Corp. Company Overview 229
5.30.1 MolecularMD, Corp. Pipeline Products & Ongoing Clinical Trials Overview 229
5.31 Multiplicom N.V. Company Overview 230
5.31.1 Multiplicom N.V. Pipeline Products & Ongoing Clinical Trials Overview 230
5.32 Myriad Genetics, Inc. Company Overview 231
5.32.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 231
5.33 Nanosphere, Inc. Company Overview 234
5.33.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 234
5.34 New York University Company Overview 237
5.34.1 New York University Pipeline Products & Ongoing Clinical Trials Overview 237
5.35 NIH Office of Technology Transfer Company Overview 238
5.35.1 NIH Office of Technology Transfer Pipeline Products & Ongoing Clinical Trials Overview 238
5.36 Oryzon Genomics S.A. Company Overview 240
5.36.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 240
5.37 Oxford Biodynamics Limited Company Overview 241
5.37.1 Oxford Biodynamics Limited Pipeline Products & Ongoing Clinical Trials Overview 241
5.38 Panagene Inc. Company Overview 246
5.38.1 Panagene Inc. Pipeline Products & Ongoing Clinical Trials Overview 246
5.39 Pangaea Biotech, S.L. Company Overview 250
5.39.1 Pangaea Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 250
5.40 PDI, lnc. Company Overview 254
5.40.1 PDI, lnc. Pipeline Products & Ongoing Clinical Trials Overview 254
5.41 PharmaSeq, Inc. Company Overview 256
5.41.1 PharmaSeq, Inc. Pipeline Products & Ongoing Clinical Trials Overview 256
5.42 Qiagen N.V. Company Overview 258
5.42.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 258
5.43 RedPath Integrated Pathology, Inc. Company Overview 268
5.43.1 RedPath Integrated Pathology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 268
5.44 Response Genetics, Inc. Company Overview 269
5.44.1 Response Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 269
5.45 Rheonix, Inc. Company Overview 272
5.45.1 Rheonix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 272
5.46 Seegene, Inc. Company Overview 274
5.46.1 Seegene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 274
5.47 Shuwen Biotech Co. Ltd. Company Overview 276
5.47.1 Shuwen Biotech Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 276
5.48 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 284
5.48.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 284
5.49 Sygnis AG Company Overview 288
5.49.1 Sygnis AG Pipeline Products & Ongoing Clinical Trials Overview 288
5.50 Sysmex Corporation Company Overview 290
5.50.1 Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview 290
5.51 The Johns Hopkins University Company Overview 292
5.51.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 292
5.52 thromboDx Company Overview 294
5.52.1 thromboDx Pipeline Products & Ongoing Clinical Trials Overview 294
5.53 Transbiomed, SL Company Overview 296
5.53.1 Transbiomed, SL Pipeline Products & Ongoing Clinical Trials Overview 296
5.54 Transgenomic, Inc. Company Overview 297
5.54.1 Transgenomic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 297
5.55 TrovaGene, Inc. Company Overview 299
5.55.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 299
5.56 University of California, Irvine Company Overview 301
5.56.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 301
5.57 Vela Diagnostics Company Overview 302
5.57.1 Vela Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 302
5.58 Xiamen Zeesan Biotech Co.,Ltd Company Overview 307
5.58.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 307
6 Acquired Gene or Chromosome Alterations- Recent Developments 311
7 Appendix 345
7.1 Methodology 345
7.2 About GlobalData 347
7.3 Contact Us 348
7.4 Disclaimer 348
【レポート販売概要】
■ タイトル:世界における後天的遺伝子変異または後天的染色体変異検査製品のパイプライン動向2015■ 英文:Acquired Gene or Chromosome Alterations - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0077EPD
■ 調査対象地域:グローバル
- HCGの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of HCG testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Dec …
- 末梢神経鞘腫瘍(神経線維肉腫):グローバル臨床試験レビュー(2014年上半期)Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H1, 2014" provides data on the Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) clinical trial scenario. This report provides elemental information and data relating to the clinical t …
- Ovarian Cancer:グローバル臨床試験レビューH2, 2013Ovarian Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2013" provides data on the Ovarian Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ovarian Cancer. It includes an overview of the trial numbers and their recruitment status as per …
- 世界のペットフード(Pet Food)市場動向(2014-2018)TechNavio's analysts forecast the Global Pet Food market to grow at a CAGR of 5.1 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in pet humanization. The Global Pet Food market has also been witnessing the growth in organized retailing. However, the increase in product recalls could pose a challenge to the growth of this market. TechNav …
- 世界のセルフチェックアウトターミナル市場動向(2012-2016)TechNavio's analysts forecast the Global Self-checkout Terminals market to grow at a CAGR of 15.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the reduction in queue size during the time of checkout. The Global Self-checkout Terminals market has also been witnessing the evolution of small size self-checkout terminals. However, the increased chance …
- インバータ・デューティ・モーターの世界市場予測(~2021)The global inverter duty motors market is projected to grow at a CAGR of 9.6% during 2016–2021, to reach a value of USD 4.08 Billion by 2021. This growth is attributed to increasing demand for energy efficiency, energy density of motors, and growing urbanization leading to infrastructural growth across the globe. The inverter duty motors market, by application, in this report, has been divided int …
- ゼオライトの世界市場:天然ゼオライト、合成ゼオライトAbout Zeolite Zeolites are alumina silicate and microporous minerals that are available naturally and also can be produced synthetically. They have a three-dimensional crystalline structure of tetrahedral arrangements of alumina or siliceous anions that are sturdily bonded at corners. The zeolite structure contains (–Si–O–Al–) linkages. These linkages form even sized pores on the surface and form …
- リップスティックの世界市場:製品種類別(マット、グロッシー、リップパウダー、その他)、フォーム別(スティック、液体、パレット)、流通経路別(スーパーマーケット/ハイパーマーケット、専門店、オンラインストア)Lipstick is a makeup product that is used for beautification of lips. The primary ingredient used to make lipstick includes waxes, oil, and pigments. The lipstick market size was valued at $8.2 billion in 2018, and is expected to reach $12.5 billion by 2026, registering a CAGR of 5.5% from 2019 to 2026. They are available in may shades and colors including nude, maroon, red, pink, purple, and othe …
- Beach Energy Limited:石油・ガスの開発・生産動向及びコスト分析– 2012Beach Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Beach Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- ナイロンモノフィラメントの世界市場分析:製品別(ナイロン6、ナイロン66)、用途別(漁網、医療、自動車、消費財)、セグメント予測、-2020The global nylon monofilaments market is expected to reach USD 1.89 billion by 2020. Growth of key end-use industries such as automotive, fishing and consumer good in Asia Pacific and Latin America is expected to remain a key driving factor for the global nylon monofilament market. Growing nylon monofilament application development in medical industry is also expected to have a positive impact on …
- CNGコンプレッサー・アフターマーケットの世界市場2017-2021About CNG Compressor Aftermarket The CNG compressor aftermarket includes spare parts used for both preventive and repair maintenance requirements of the equipment. The aftermarket excludes service charges. CNG compressor replacement and spare parts. Technavio’s analysts forecast the global CNG compressor aftermarket to grow at a CAGR of 2.42% during the period 2017-2021. [Covered in this report] T …
- 世界の航空機市場動向(2012-2016)TechNavio's analysts forecast the Global Aircrafts market to grow at a CAGR of 6.32 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing revenue per kilometer and freight ton kilometer of aircrafts across the globe. The Global Aircrafts market has also been witnessing increased aircraft growth in the APAC region. However, the increasing pri …
- Saudi ArabiaのNitric Acid, Sulphonitric Acids市場:貿易(輸入、輸出)動向This market research report examines the foreign trade of Saudi Arabia and its perspectives on the global market for nitric acid, sulphonitric acids. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on nitric acid, sulphonitric acids export/import operations in Saudi Arab …
- 電力変電所オートメーションの世界市場:インテリジェント電子デバイス(IED)、遠隔端末装置(RTU)、PLC、BCUThe electric power substation automation has completely transformed the way substations are controlled and critical information is gathered. The global electric power substation automation market is majorly governed by the automation components and Intelligent Electronic Devices (IEDs) such as digital protection relays, RTUs, logical programmable controllers, digital transducers, recloser controls …
- 産業用ボイラーの世界市場2015-2019About Industrial Boiler An industrial boiler is a closed vessel used to generate steam for various industrial heating and humidification applications. The boiler has a heat source (furnace), which boils water at a rate higher than its boiling point, and a heat transfer medium (pipes or tubes for heat exchange). Many industrial boiler vendors offer superior quality and customized industry-specific …